Basic Information
| LncRNA/CircRNA Name | LL22NC03-N64E9.1 |
| Synonyms | NA |
| Region | GRCh38_22:15796959-15798346 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, etc. |
| Sample | lung cancer tissues, cell lines (BEAS-2B, A549, H1703, H292) |
| Expression Pattern | up-regulated |
| Function Description | LL22NC03-N64E9.1, promoted proliferation of lung cancer cells in vitro, was highly expressed in lung cancer tissues and was associated with increased overall survival (OS), tumor size, and tumor stage in patients with lung cancer. |
| Pubmed ID | 29935018 |
| Year | 2018 |
| Title | A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer. |
External Links
| Links for LL22NC03-N64E9.1 | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |